Regencell Bioscience Holdings Limited (RGC)

NASDAQ: RGC · IEX Real-Time Price · USD

6.49

+0.62 (10.56%)

At close: May 2, 2024, 4:00 PM

5.33

-1.16 (-17.87%)

After-hours: May 3, 2024, 4:21 PM EDT

RGC Balance Sheet

Financials in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	1.56	6.42	0.06	0.39	0.24
Short-Term Investments	10	10	0	0	0
Cash & Cash Equivalents	11.56	16.42	0.06	0.39	0.24
Cash Growth	-29.56%	27532.00%	-84.65%	59.05%	-
Receivables	0.06	0.03	0.01	0	0
Total Current Assets	11.62	16.44	0.07	0.39	0.24
Property, Plant & Equipment	0.89	1.46	0.08	0.11	0
Long-Term Investments	0.11	0.11	0.02	0.02	0
Other Long-Term Assets	0	0	0.17	0	0
Total Long-Term Assets	1	1.57	0.27	0.13	0
Total Assets	12.62	18.02	0.34	0.51	0.24
Accounts Payable	0.01	0.02	0.08	0	0
Current Debt	0.44	0.41	3.68	3.07	2.08
Other Current Liabilities	0.16	0.15	0.57	0.1	0
Total Current Liabilities	0.61	0.58	4.34	3.16	2.08
Long-Term Debt	0.03	0.36	0	0	0
Total Long-Term Liabilities	0.03	0.36	0	0	0
Total Liabilities	0.63	0.94	4.34	3.16	2.08
Total Debt	0.46	0.77	3.68	3.07	2.08
Debt Growth	-39.88%	-79.05%	19.94%	47.46%	-
Retained Earnings	-17.32	-11.44	-4	-2.65	-1.84
Comprehensive Income	-0.09	0	0	0	0
Shareholders' Equity	12.03	17.07	-4	-2.65	-1.84
Net Cash / Debt	11.1	15.65	-3.62	-2.68	-1.84
Net Cash / Debt Growth	-29.05%	-	-	-	-
Net Cash Per Share	0.85	1.22	-0.36	-0.27	-0.18
Working Capital	11.01	15.87	-4.27	-2.78	-1.84
Book Value Per Share	0.92	1.33	-0.40	-0.27	-0.18

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).